Novavax (NVAX) EBITDA (2010 - 2026)
Novavax (NVAX) recorded EBITDA of -$51.85 million in Q2 2026, compared with $108.63 million a year earlier.
Powered by 
Analysis
Novavax (NVAX) EBITDA (2010 - 2026) Analysis & Trends
On a TTM basis, Novavax's EBITDA came in at -$216.3 million as of Jun 30, 2026; for FY2025, it was $480.41 million.
- Across earlier years, EBITDA came in at -$200.44 million in FY2024, -$525.29 million in FY2023, -$615.68 million in FY2022 and -$1.67 billion in FY2021.
- Quarterly EBITDA has ranged from -$821.3 million in Q4 2021 to $523.85 million in Q1 2025 over the past five years.
- Per Business Quant, the preceding three quarters came in at -$12.37 million (Q1 2026), $19.36 million (Q4 2025) and -$171.43 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Novavax | 1.78 Bn | -1.23 Bn | 42.45 Mn | -51.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -51.85 Mn |
| Mar 31, 2026 | -12.37 Mn |
| Dec 31, 2025 | 19.36 Mn |
| Sep 30, 2025 | -171.43 Mn |
| Jun 30, 2025 | 108.63 Mn |
| Mar 31, 2025 | 523.85 Mn |
| Dec 31, 2024 | -118.56 Mn |
| Sep 30, 2024 | -121.32 Mn |
| Jun 30, 2024 | 172.13 Mn |
| Mar 31, 2024 | -132.68 Mn |
| Dec 31, 2023 | -172.77 Mn |
| Sep 30, 2023 | -114.31 Mn |
| Jun 30, 2023 | 65.52 Mn |
| Mar 31, 2023 | -303.73 Mn |
| Dec 31, 2022 | -236.66 Mn |
| Sep 30, 2022 | -118.84 Mn |
| Jun 30, 2022 | -476.24 Mn |
| Mar 31, 2022 | 216.06 Mn |
| Dec 31, 2021 | -821.30 Mn |
| Sep 30, 2021 | -302.88 Mn |
API Access
Novavax EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();